Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  • P. Y.K. Van den Bergh
  • , R. D.M. Hadden
  • , Pierre Bouche
  • , D. R. Cornblath
  • , A. Hahn
  • , I. Illa
  • , C. L. Koski
  • , J. M. Léger
  • , E. Nobile-Orazio
  • , J. Pollard
  • , C. Sommer
  • , P. A. van Doorn
  • , I. N. van Schaik

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationEuropean Handbook of Neurological Management
Subtitle of host publicationSecond Edition
PublisherWiley-Blackwell
Pages333-341
Number of pages9
Volume1
ISBN (Print)9781405185332
DOIs
StatePublished - Sep 6 2010

Keywords

  • Aim to update EFNS/PNS guideline on management of CIDP-based on newly available evidence
  • Chronic inflammatory demyelinating polyradiculoneuropathy
  • Dearth of evidence, concerning general aspects of treatment for symptoms of CIDP-as pain and fatigue
  • Demyelinating polyradiculoneuropathy-and electrodiagnostic criteria
  • Different sets of diagnostic criteria for CIDP-sensitivity and specificity varying
  • Good Practice Points for defining diagnostic criteria for CIDP-initial management
  • Immunosuppressant and immunomodulatory drugs-beneficial in CIDP (Class IV evidence)
  • Intravenous immunoglobulin-showing that IVIg 2.0 g/kg produces significant improvement in disability lasting 2-6 weeks
  • No evidence-based guideline-as none of trials, systematically assessed long-term management
  • Supportive features for diagnosis of CIDP-macrophage-associated demyelination, onion bulb formation, demyelinated and remyelinated nerve fibres

ASJC Scopus subject areas

  • General Neuroscience
  • General Medicine

Cite this